Mark Stavro

Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes.

Vladimir Vuksan, Mark Stavro, John L. Sievenpiper et al. · Diabetes Care · 2000 · 169 citations · Full text

Medicine, Pharmacotherapy, Bioavailability +15

American ginseng ( Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals

Vladimir Vuksan, John L. Sievenpiper, Julia MW Wong et al. · American Journal of Clinical Nutrition · 2001 · 127 citations

Medicine, Pharmacology, Glycobiology +5

American Ginseng Improves Glycemia in Individuals with Normal Glucose Tolerance: Effect of Dose and Time Escalation

Vladimir Vuksan, Mark Stavro, John L. Sievenpiper et al. · Journal of the American College of Nutrition · 2000 · 89 citations

Medicine, Clinical Pharmacokinetics, Bioavailability +16

Five batches representative of Ontario-grown American ginseng root produce comparable reductions of postprandial glycemia in healthy individualsThis article is one of a selection of papers published in this special issue (part 1 of 2) on the Safety and Efficacy of Natural Health Products.

Anamaria Dascalu, John L. Sievenpiper, Alexandra L. Jenkins et al. · Canadian Journal of Physiology and Pharmacology · 2007 · 19 citations

Medicine, Nutrition, Diabetology +16

Konjac-mannan and American ginsing: Emerging alternative therapies for type 2 diabetes mellitus - Discussion

Vladimir Vuksan, John L. Sievenpiper, Zheng Xu et al. · Journal of the American College of Nutrition · 2001 · 14 citations

Medicine, Nutrition, Nutritional Sciences +12